T1	CHEM 71 82	liraglutida
#1	AnnotatorNotes T1	C1456408; liraglutide; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T2	CHEM 102 112	metformina
#2	AnnotatorNotes T2	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T3	CHEM 132 142	metformina
#3	AnnotatorNotes T3	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T4	PROC 146 157	monoterapia
#4	AnnotatorNotes T4	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T5	PROC 164 186	control de la glucemia
#5	AnnotatorNotes T5	C3669205; Blood glucose monitoring; Therapeutic or Preventive Procedure | C5392125; Glycemic Control; Therapeutic or Preventive Procedure | C3267174; Glycaemia control; Therapeutic or Preventive Procedure
T6	DISO 215 233	diabetes de tipo 2
#6	AnnotatorNotes T6	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T7	CHEM 275 286	liraglutida
#7	AnnotatorNotes T7	C1456408; liraglutide; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T8	CHEM 306 316	metformina
#8	AnnotatorNotes T8	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T9	CHEM 336 346	metformina
#9	AnnotatorNotes T9	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T10	DISO 375 393	diabetes de tipo 2
#10	AnnotatorNotes T10	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T11	DISO 418 442	Diabetes Mellitus Tipo 2
#11	AnnotatorNotes T11	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T12	DISO 464 479	Diabetes Tipo 2
#12	AnnotatorNotes T12	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T13	PROC 667 678	Diagnóstico
#13	AnnotatorNotes T13	C0011900; Diagnosis; Diagnostic Procedure
T14	DISO 682 709	diabetes mellitus de tipo 2
#14	AnnotatorNotes T14	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T15	PROC 712 723	tratamiento
#15	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	CHEM 822 832	metformina
#16	AnnotatorNotes T16	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T17	PROC 836 847	monoterapia
#17	AnnotatorNotes T17	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T18	CHEM 861 871	metformina
#18	AnnotatorNotes T18	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T19	PROC 793 802	ejercicio
#19	AnnotatorNotes T19	C0452240; Physical therapy exercises; Therapeutic or Preventive Procedure
T20	PROC 1033 1044	tratamiento
#20	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T21	CHEM 1152 1162	metformina
#21	AnnotatorNotes T21	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T22	DISO 1298 1316	Diabetes de tipo 1
#22	AnnotatorNotes T22	C0011854; Diabetes Mellitus, Insulin-Dependent; Disease or Syndrome
T23	DISO 1320 1362	Diabetes juvenil de comienzo en la madurez
#23	AnnotatorNotes T23	C0342276; Maturity onset diabetes mellitus in young; Disease or Syndrome
T24	DISO 1364 1368	MODY
#24	AnnotatorNotes T24	C0342276; Maturity onset diabetes mellitus in young; Disease or Syndrome
T25	CHEM 1388 1402	antidiabéticos
#25	AnnotatorNotes T25	C0935929; Antidiabetics; Pharmacologic Substance
T26	CHEM 1416 1426	metformina
#26	AnnotatorNotes T26	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T27	PROC 1490 1501	tratamiento
#27	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	PROC 1191 1194	IMC
#28	AnnotatorNotes T28	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T29	CHEM 1520 1528	insulina
#29	AnnotatorNotes T29	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T30	DISO 1532 1544	Hipoglucemia
#30	AnnotatorNotes T30	C0020615; Hypoglycemia; Disease or Syndrome
T31	DISO 1605 1617	hipoglucemia
#31	AnnotatorNotes T31	C0020615; Hypoglycemia; Disease or Syndrome
T32	DISO 1672 1692	pancreatitis crónica
#32	AnnotatorNotes T32	C0149521; Pancreatitis, Chronic; Disease or Syndrome
T33	DISO 1695 1724	pancreatitis aguda idiopática
#33	AnnotatorNotes T33	C0341461; Idiopathic acute pancreatitis; Disease or Syndrome
T34	DISO 1738 1747	trastorno
#34	AnnotatorNotes T34	C0012634; Disease; Disease or Syndrome
T35	DISO 1824 1842	diabetes de tipo 2
#35	AnnotatorNotes T35	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T36	PROC 761 770	ejercicio
#36	AnnotatorNotes T36	C0452240; Physical therapy exercises; Therapeutic or Preventive Procedure
T37	DISO 1928 1940	Hipertensión
#37	AnnotatorNotes T37	C0020538; Hypertensive disease; Disease or Syndrome
T38	PROC 1969 1976	tratada
#38	AnnotatorNotes T38	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T39	DISO 2041 2046;2071 2094	Abuso de alcohol o narcóticos
T40	PROC 1956 1963	tratado
#39	AnnotatorNotes T40	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T41	PROC 626 637	doble ciego
#40	AnnotatorNotes T41	C0013072; Double-Blind Method; Research Activity
T42	DISO 178 186	glucemia
#41	AnnotatorNotes T42	C2585282; Blood glucose concentration; Finding
T43	PROC 753 758	dieta
#42	AnnotatorNotes T43	C0012159; Diet therapy; Health Care Activity | C0600072; Feeding and dietary regimes; Therapeutic or Preventive Procedure
T44	PROC 785 790	dieta
#43	AnnotatorNotes T44	C0012159; Diet therapy; Health Care Activity | C0600072; Feeding and dietary regimes; Therapeutic or Preventive Procedure
T45	PROC 974 979	HbA1c
#44	AnnotatorNotes T45	C0202054; Glucohemoglobin measurement; Laboratory Procedure
T46	PROC 1057 1062	dieta
#45	AnnotatorNotes T46	C0012159; Diet therapy; Health Care Activity | C0600072; Feeding and dietary regimes; Therapeutic or Preventive Procedure
T47	PROC 1166 1189	Índice de masa corporal
#46	AnnotatorNotes T47	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T48	ANAT 1181 1189	corporal
#47	AnnotatorNotes T48	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T49	PROC 1065 1074	ejercicio
#48	AnnotatorNotes T49	C0452240; Physical therapy exercises; Therapeutic or Preventive Procedure
T50	Date 12 16	2011
T51	LIVB 190 195	niños
#49	AnnotatorNotes T51	C0008059; Child; Age Group
T52	LIVB 350 355	niños
#50	AnnotatorNotes T52	C0008059; Child; Age Group
T53	LIVB 509 514	Niños
#51	AnnotatorNotes T53	C0008059; Child; Age Group
T54	Age 530 545	de 10 a 17 años
T55	LIVB 559 566	sujetos
#52	AnnotatorNotes T55	C0681850; Study Subject; Group
T56	Neg_cue 567 569	no
T57	Age 585 592	18 años
T58	Duration 641 651	14 semanas
T59	Duration 732 748	al menos 90 días
T60	Duration 911 927	al menos 30 días
T67	LIVB 1129 1135	sujeto
#53	AnnotatorNotes T67	C0681850; Study Subject; Group
T69	Duration 1430 1441	los 90 días
T70	Date 1502 1515	a corto plazo
T73	LIVB 1640 1652	investigador
#54	AnnotatorNotes T73	C0035173; Research Personnel; Professional or Occupational Group
T74	Duration 1685 1692	crónica
#55	AnnotatorNotes T74	C0205191; chronic; Temporal Concept
T76	LIVB 1863 1875	investigador
#56	AnnotatorNotes T76	C0035173; Research Personnel; Professional or Occupational Group
T79	Neg_cue 1966 1968	no
T80	LIVB 2032 2037	niños
#57	AnnotatorNotes T80	C0008059; Child; Age Group
T82	LIVB 198 210	adolescentes
#58	AnnotatorNotes T82	C0205653; Adolescent (age group); Age Group
T83	LIVB 358 370	adolescentes
#59	AnnotatorNotes T83	C0205653; Adolescent (age group); Age Group
T84	LIVB 517 529	adolescentes
#60	AnnotatorNotes T84	C0205653; Adolescent (age group); Age Group
T85	LIVB 1227 1244	población general
#61	AnnotatorNotes T85	C0683971; General Population; Population Group
T61	Neg_cue 1403 1415	distintos de
T62	CHEM 2084 2094	narcóticos
#62	AnnotatorNotes T62	C0027415; Narcotics; Hazardous or Poisonous Substance · Pharmacologic Substance
T63	Quantifier_or_Qualifier 968 969	1
T64	Quantifier_or_Qualifier 660 662	11
T65	PROC 1455 1474	visita de selección
#64	AnnotatorNotes T65	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T66	PROC 940 959	visita de selección
#65	AnnotatorNotes T66	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T68	PROC 653 659	visita
#66	AnnotatorNotes T68	C1512346; Patient Visit; Health Care Activity
T71	PROC 961 967	visita
#67	AnnotatorNotes T71	C1512346; Patient Visit; Health Care Activity
A1	Population_data T51 Age
A2	Population_data T82 Age
A3	Population_data T52 Age
A4	Population_data T83 Age
A5	Population_data T53 Age
A6	Population_data T84 Age
A7	Assertion T57 Negated
A13	Assertion T26 Negated
A14	Assertion T38 Negated
A15	Population_data T80 Age
A16	Status T35 History_of
A17	Status T32 History_of
A18	Status T33 History_of
A19	Assertion T39 Speculated
#68	AnnotatorNotes T70	C0443303; short-term; Temporal Concept 
#69	AnnotatorNotes T39	C0524661; Narcotic Abuse; Mental or Behavioral Dysfunction + C0085762; Alcohol abuse; Mental or Behavioral Dysfunction 
T72	Neg_cue 1941 1943	no
T75	Quantifier_or_Qualifier 1944 1954	controlada
A8	Assertion T75 Negated
T77	Neg_cue 1579 1587	falta de
T78	PHYS 1588 1598	conciencia
A9	Assertion T78 Negated
#63	AnnotatorNotes T78	C0009790; Conscience; Mental Process
T81	Spec_cue 1877 1884	pudiera
T86	CONC 1885 1895	interferir
A10	Assertion T86 Speculated
#70	AnnotatorNotes T86	C0521102; Interferes with; Functional Concept
R1	Speculation Arg1:T81 Arg2:T86	
T87	Neg_cue 1773 1778	salvo
T88	Observation 1783 1791	procesos
A11	Assertion T88 Negated
#71	AnnotatorNotes T88	C4745084; Medical Condition; Finding
R2	Causes Arg1:T35 Arg2:T88	
R3	Negation Arg1:T87 Arg2:T88	
R4	Negation Arg1:T56 Arg2:T57	
R5	Negation Arg1:T61 Arg2:T26	
R6	Negation Arg1:T77 Arg2:T78	
R7	Overlap Arg1:T78 Arg2:T31	
R8	Negation Arg1:T72 Arg2:T75	
R9	Negation Arg1:T79 Arg2:T38	
T89	Food 2074 2081	alcohol
#72	AnnotatorNotes T89	C0001967; Alcoholic Beverages; Food
R10	Combined_with Arg1:T1 Arg2:T2	
R11	Used_for Arg1:T3 Arg2:T4	
R12	Used_for Arg1:T1 Arg2:T5	
R13	Used_for Arg1:T3 Arg2:T5	
R15	Experiences Arg1:T51 Arg2:T1	
R16	Experiences Arg1:T51 Arg2:T3	
R17	Experiences Arg1:T82 Arg2:T1	
R18	Experiences Arg1:T82 Arg2:T3	
R19	Experiences Arg1:T51 Arg2:T6	
R20	Experiences Arg1:T82 Arg2:T6	
R21	Causes Arg1:T6 Arg2:T42	
R22	Combined_with Arg1:T7 Arg2:T8	
R23	Experiences Arg1:T52 Arg2:T9	
R24	Experiences Arg1:T52 Arg2:T7	
R25	Experiences Arg1:T83 Arg2:T7	
R26	Experiences Arg1:T83 Arg2:T9	
T90	Quantifier_or_Qualifier 327 331	sólo
R27	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T90	
R28	Experiences Arg1:T52 Arg2:T10	
R29	Experiences Arg1:T83 Arg2:T10	
R30	Has_Age Arg1:T53 Arg2:T54	
R31	Has_Age Arg1:T84 Arg2:T54	
R32	Has_Age Arg1:T55 Arg2:T57	
R33	Before Arg1:T41 Arg2:T57	
R34	Before Arg1:T68 Arg2:T57	
R35	Has_Quantifier_or_Qualifier Arg1:T68 Arg2:T64	
R36	Has_Duration_or_Interval Arg1:T41 Arg2:T58	
R37	Overlap Arg1:T68 Arg2:T58	
R38	Has_Duration_or_Interval Arg1:T15 Arg2:T59	
R39	Combined_with Arg1:T43 Arg2:T36	
R40	Has_Duration_or_Interval Arg1:T43 Arg2:T59	
R41	Has_Duration_or_Interval Arg1:T36 Arg2:T59	
R42	Combined_with Arg1:T44 Arg2:T19	
R43	Combined_with Arg1:T19 Arg2:T16	
R44	Used_for Arg1:T16 Arg2:T17	
R45	Has_Duration_or_Interval Arg1:T16 Arg2:T59	
T91	Dose 852 857;895 902	dosis estable
R47	Has_Dose_or_Strength Arg1:T18 Arg2:T91	
R46	Has_Duration_or_Interval Arg1:T91 Arg2:T60	
R48	Before Arg1:T18 Arg2:T66	
R49	Before Arg1:T18 Arg2:T71	
R50	Has_Quantifier_or_Qualifier Arg1:T71 Arg2:T63	
T92	Result_or_Value 982 1026	Mayor o igual a 7,0 % y menor o igual a 11 %
R51	Combined_with Arg1:T46 Arg2:T49	
T93	Result_or_Value 1078 1122	Mayor o igual a 6,5 % y menor o igual a 11 %
R52	Experiences Arg1:T67 Arg2:T21	
R53	Location_of Arg1:T48 Arg2:T47	
R54	Location_of Arg1:T48 Arg2:T28	
T94	Result_or_Value 1196 1220	superior al percentil 85
R55	Has_Result_or_Value Arg1:T47 Arg2:T94	
R56	Has_Result_or_Value Arg1:T28 Arg2:T94	
R57	Experiences Arg1:T85 Arg2:T47	
R58	Experiences Arg1:T85 Arg2:T28	
R59	Overlap Arg1:T25 Arg2:T69	
R61	Before Arg1:T25 Arg2:T65	
R60	Overlap Arg1:T29 Arg2:T70	
R62	Used_for Arg1:T29 Arg2:T27	
T95	Quantifier_or_Qualifier 1545 1552	intensa
#73	AnnotatorNotes T95	C0522510; With intensity; Qualitative Concept
R63	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T95	
T96	Quantifier_or_Qualifier 1555 1565	importante
#74	AnnotatorNotes T96	C3898777; Important; Qualitative Concept
R64	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T96	
T97	Observation 1566 1576	recurrente
#75	AnnotatorNotes T97	C0679254; Disease recurrence; Finding
R65	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T97	
R66	Has_Duration_or_Interval Arg1:T32 Arg2:T74	
T98	Quantifier_or_Qualifier 1748 1771	con importancia clínica
#76	AnnotatorNotes T98	C3898777; Important; Qualitative Concept
R67	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T98	
T99	PROC 1918 1924	ensayo
#77	AnnotatorNotes T99	C0008976; Clinical Trials; Research Activity
R69	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T75	
T100	Result_or_Value 1978 2028	por encima del percentil 99 para la edad y el sexo
R70	Has_Result_or_Value Arg1:T37 Arg2:T100	
R71	Experiences Arg1:T80 Arg2:T37	
R72	Experiences Arg1:T80 Arg2:T40	
R73	Experiences Arg1:T80 Arg2:T38	
R74	Causes Arg1:T89 Arg2:T39	
R75	Causes Arg1:T62 Arg2:T39	
T101	Spec_cue 2060 2070	sospechado
R76	Speculation Arg1:T101 Arg2:T39	
R14	Experiences Arg1:T51 Arg2:T42	
R77	Experiences Arg1:T82 Arg2:T42	
R78	Experiences Arg1:T55 Arg2:T68	
#78	AnnotatorNotes T90	C0205171; Singular; Quantitative Concept
#79	AnnotatorNotes T63	C0205447; One; Quantitative Concept
A12	Assertion T46 Hypothetical
A20	Assertion T49 Hypothetical
A21	Experiencer T67 Patient
A22	Assertion T21 Hypothetical
A23	Experiencer T85 Patient
A24	Experiencer T51 Patient
A25	Experiencer T82 Patient
A26	Experiencer T52 Patient
A27	Experiencer T83 Patient
A28	Experiencer T55 Patient
A29	Experiencer T73 Other
A30	Experiencer T76 Other
A31	Experiencer T80 Patient
